Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Qingdao Haier Biomedical CoSHSE:688139 +1.04%82 Interest Coverage is 101.77 as of Mar. 2026, which is 22% below its 10-year median of 130.49. GuruFocus rates SHSE:688139 with a GF Score™ of 82/100 and a GF Value™ of ¥36.05 (Modestly Undervalued). The stock has 7 warning signs investors should review. Among 464 Medical Devices & Instruments companies, Qingdao Haier Biomedical Co ranks better than 67.46% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. Qingdao Haier Biomedical Co's
Operating Income
for the
three
months ended in Mar. 2026 was ¥90 Mil. Qingdao Haier Biomedical Co's Interest Expense for the
three
months ended in Mar. 2026 was ¥-1 Mil.
Qingdao Haier Biomedical Co's interest coverage for the quarter that ended in Mar. 2026 was 101.77.
The higher the ratio, the stronger the company's financial strength is.
Good Sign:
Ben Graham prefers companies' interest coverage to be at least 5. Qingdao Haier Biomedical Co Ltd has enough cash to cover all of its debt. Its financial situation is stable.
The historical rank and industry rank for Qingdao Haier Biomedical Co's Interest Coverage or its related term are showing as below:
SHSE:688139'
s Interest Coverage Range Over the Past 10 Years
Min: 3.32 Med: 130.49 Max: No Debt
Current: 53.33
SHSE:688139's Interest Coverage is ranked better than 67.46% of 464
companies
in the Medical Devices & Instruments industry
Industry Median: 16.08
vs SHSE:688139: 53.33
Qingdao Haier Biomedical Co (SHSE:688139) Interest Coverage Explanation
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
Qingdao Haier Biomedical Co Interest Coverage Related Terms
Qingdao Haier Biomedical Co Interest Coverage Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
Qingdao Haier Biomedical Co Interest Coverage Chart
SHSE:688139 vs ABT, SYK, MDT: Interest Coverage Comparison
For the Medical Devices subindustry, Qingdao Haier Biomedical Co's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qingdao Haier Biomedical Co Interest Coverage vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's Interest Coverage distribution charts can be found below:
* The bar in red indicates where Qingdao Haier Biomedical Co's Interest Coverage falls into.
Qingdao Haier Biomedical Co Interest Coverage Calculation
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qingdao Haier Biomedical Co (SHSE:688139) has a Interest Coverage of 101.77 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Qingdao Haier Biomedical Co and its competitors. This is 22% below median its historical median of 130.49. Over the past decade, Qingdao Haier Biomedical Co's Interest Coverage has ranged from 3.32 to 10,000.00. According to the industry distribution chart, Qingdao Haier Biomedical Co ranks #151 out of 464 companies in the Medical Devices & Instruments industry, placing it in the top 32.5%.
Is Qingdao Haier Biomedical Co's Interest Coverage too high?
Qingdao Haier Biomedical Co's current Interest Coverage of 101.77 is 22% below median its 10-year median of 130.49. Over the past 10 years, this metric has ranged from a low of 3.32 to a high of 10,000.00. The Medical Devices & Instruments industry median Interest Coverage is 16.08. Qingdao Haier Biomedical Co's value of 101.77 is 532.9% above this industry median. Based on the distribution chart, Qingdao Haier Biomedical Co ranks #151 out of 464 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Qingdao Haier Biomedical Co has a GF Score™ of 82/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qingdao Haier Biomedical Co's Interest Coverage compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Qingdao Haier Biomedical Co ranks #151 out of 464 companies for Interest Coverage. This puts Qingdao Haier Biomedical Co in the upper half of its industry. The industry median Interest Coverage is 16.08. Qingdao Haier Biomedical Co's value of 101.77 is 532.9% above this benchmark. Historically, Qingdao Haier Biomedical Co's own Interest Coverage has ranged from 3.32 to 10,000.00 over the past decade. While the company's 10-year median is 130.49 vs. the industry median of 16.08, Qingdao Haier Biomedical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Medical Devices & Instruments company?
The median Interest Coverage among Medical Devices & Instruments companies is 16.08, based on 464 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qingdao Haier Biomedical Co's current Interest Coverage of 101.77 is 532.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on Qingdao Haier Biomedical Co and its competitors. For the Medical Devices & Instruments industry, the median Interest Coverage is 16.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qingdao Haier Biomedical Co's current Interest Coverage is 101.77, which is 22% below median its own 10-year median of 130.49. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qingdao Haier Biomedical Co stock overvalued right now?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co (SHSE:688139) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥36.05, compared to a current price of ¥28.18 — trading 21.8% below its estimated fair value. The current Interest Coverage is 101.77, which is 22% below median its 10-year median of 130.49 and 532.9% above the Medical Devices & Instruments industry median of 16.08. Qingdao Haier Biomedical Co's overall GF Score™ is 82/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For Qingdao Haier Biomedical Co (SHSE:688139), the current Interest Coverage is 101.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qingdao Haier Biomedical Co (SHSE:688139) Overvalued in 2026?
Based on GuruFocus' analysis, Qingdao Haier Biomedical Co stock appears to be undervalued.
The current stock price of ¥28.18 is trading 21.8% below its estimated GF Value™ of ¥36.05.
GuruFocus considers Qingdao Haier Biomedical Co to be Modestly Undervalued.
Key valuation signals for SHSE:688139:
Interest Coverage: 101.77 (22% below median its 10-year median of 130.49)
GF Value™: ¥36.05 vs. price of ¥28.18 (21.8% below fair value)
Industry Position: 532.9% above the Medical Devices & Instruments median (#151 of 464)
No single metric tells the full story. See the SHSE:688139 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
82GF Score
Get the complete analysis for SHSE:688139
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688139 has been successfully added to your 
